Author:
Andersen Mads Hald,Becker Jürgen C.,Straten Per thor
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference111 articles.
1. Van den Eynde, B. J. & Boon, T. Tumor antigens recognized by T lymphocytes. Int. J. Clin. Lab. Res. 27, 81–86 (1997).
2. Andersen, M. H., Pedersen, L. O., Becker, J. C. & thor Straten, P. Identification of a cytotoxic T lymphocyte response to the apoptose inhibitor protein survivin in cancer patients. Cancer Res. 61, 869–872 (2001). First description of natural immunity against survivin in cancer patients.
3. Nestle, F. O. et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med. 4, 328–332 (1998).
4. Smyth, M. J., Godfrey, D. I. & Trapani, J. A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunol. 2, 293–299 (2001).
5. Jocham, D. et al. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet 363, 594–599 (2004). Data from the first Phase III vaccination trial suggesting that therapeutic vaccination might have an impact on disease.
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献